Shares of several obesity drugmakers dip after LLY lowered its revenue outlook for 2024 amid slower-than-expected sales ...

Analysis of CMC's mixed Q1 results with revenue declines and margin pressures, but strong performance in the North American ...

Abneesh Roy from Nuvama shares insights on the expected impact of the Union Budget on consumption. He is positive on Trent's ...

Progyny, Inc., a strong player in the fertility benefits market, is undervalued with solid growth potential, making it a good ...

Four heads of iconic U.S. enterprises face turbulent, inherited challenges with elevated investor anxiety in 2025.